Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma.

Niekamp A, Abdel-Wahab R, Kuban J, Odisio BC, Mahvash A, Hassan MM, Qayyum A, Kaseb A, Sheth RA.

J Clin Med. 2018 Apr 14;7(4). pii: E83. doi: 10.3390/jcm7040083.

2.

Thrombosis in cancer patients: etiology, incidence, and management.

Sheth RA, Niekamp A, Quencer KB, Shamoun F, Knuttinen MG, Naidu S, Oklu R.

Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S178-S185. doi: 10.21037/cdt.2017.11.02. Review.

3.

Palliative Embolization for Refractory Bleeding.

Niekamp A, Sheth RA, Kuban J, Avritscher R, Ganguli S.

Semin Intervent Radiol. 2017 Dec;34(4):387-397. doi: 10.1055/s-0037-1608862. Epub 2017 Dec 14. Review.

4.

Development of a predictive model for 6 month survival in patients with venous thromboembolism and solid malignancy requiring IVC filter placement.

Huang SY, Odisio BC, Sabir SH, Ensor JE, Niekamp AS, Huynh TT, Kroll M, Gupta S.

J Thromb Thrombolysis. 2017 Jul;44(1):30-37. doi: 10.1007/s11239-017-1493-1.

5.

Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status.

Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C.

Ann Surg. 2017 Dec;266(6):1045-1054. doi: 10.1097/SLA.0000000000002018.

PMID:
27735824

Supplemental Content

Loading ...
Support Center